An abbreviated drug application (ADA) is a request submitted to the U.S. Food and Drug Administration (FDA) for the approval of a drug. This application relies on the existing approval of another drug that contains the same active ingredient, demonstrating that it is safe and effective. The ADA process allows for quicker access to medications by using data from previously approved drugs.
The term abbreviated drug application is primarily used in the context of pharmaceutical law and regulatory compliance. It is relevant in areas such as drug approval processes and intellectual property law, particularly concerning generic drugs. Users can utilize legal forms and templates to navigate the application process, ensuring compliance with FDA regulations.
Here are a couple of examples of abatement:
Example 1: A pharmaceutical company submits an abbreviated drug application for a generic version of a well-known pain reliever. They reference the original drug's safety and efficacy data to gain FDA approval.
Example 2: A manufacturer files a supplement to their abbreviated drug application to expand the approved uses of their drug to include a new treatment indication. (hypothetical example)
The primary statute governing abbreviated drug applications is the Federal Food, Drug, and Cosmetic Act, specifically:
| Term | Description | Key Differences |
|---|---|---|
| New Drug Application (NDA) | A request for approval of a new drug that has not been previously approved. | NDAs require more extensive clinical data than ADAs, as they pertain to new drugs rather than generics. |
| Abbreviated New Drug Application (ANDA) | A specific type of abbreviated drug application for generic drugs. | ANDA is a subset of ADA focused specifically on generics, whereas ADA can apply to both generics and some new indications. |
If you are involved in the pharmaceutical industry and are considering submitting an abbreviated drug application, it is advisable to:
Browse our library of 85,000+ state-specific legal templates.
| Attribute | Details |
|---|---|
| Typical Fees | Varies based on application type and legal assistance required. |
| Jurisdiction | Federal (FDA regulations) |
| Possible Penalties | Rejection of application; potential legal consequences for non-compliance. |
The purpose is to expedite the approval process for drugs that are similar to already approved medications.